These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 22486333)

  • 1. Fitness supplements as a gateway substance for anabolic-androgenic steroid use.
    Hildebrandt T; Harty S; Langenbucher JW
    Psychol Addict Behav; 2012 Dec; 26(4):955-62. PubMed ID: 22486333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychosocial correlates of gap time to anabolic-androgenic steroid use.
    Klimek P; Hildebrandt T
    Int J Eat Disord; 2018 Jun; 51(6):535-541. PubMed ID: 29542171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic dilemma of pathological appearance and performance enhancing drug use.
    Hildebrandt T; Lai JK; Langenbucher JW; Schneider M; Yehuda R; Pfaff DW
    Drug Alcohol Depend; 2011 Mar; 114(1):1-11. PubMed ID: 21115306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of the appearance and performance enhancing drug use schedule.
    Hildebrandt T; Langenbucher JW; Lai JK; Loeb KL; Hollander E
    Addict Behav; 2011 Oct; 36(10):949-58. PubMed ID: 21640487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling population heterogeneity in appearance- and performance-enhancing drug (APED) use: applications of mixture modeling in 400 regular APED users.
    Hildebrandt T; Langenbucher JW; Carr SJ; Sanjuan P
    J Abnorm Psychol; 2007 Nov; 116(4):717-33. PubMed ID: 18020718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting future anabolic-androgenic steroid use intentions with current substance use: findings from an internet-based survey.
    Dunn M; Mazanov J; Sitharthan G
    Clin J Sport Med; 2009 May; 19(3):222-7. PubMed ID: 19423975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body image and attitudes toward male roles in anabolic-androgenic steroid users.
    Kanayama G; Barry S; Hudson JI; Pope HG
    Am J Psychiatry; 2006 Apr; 163(4):697-703. PubMed ID: 16585446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychological and physical impact of anabolic-androgenic steroid dependence.
    Ip EJ; Lu DH; Barnett MJ; Tenerowicz MJ; Vo JC; Perry PJ
    Pharmacotherapy; 2012 Oct; 32(10):910-9. PubMed ID: 23033230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of anabolic androgenic steroids and polypharmacy: a review of the literature.
    Dodge T; Hoagland MF
    Drug Alcohol Depend; 2011 Apr; 114(2-3):100-9. PubMed ID: 21232881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anabolic steroid use and body image psychopathology in men: Delineating between appearance- versus performance-driven motivations.
    Murray SB; Griffiths S; Mond JM; Kean J; Blashill AJ
    Drug Alcohol Depend; 2016 Aug; 165():198-202. PubMed ID: 27364377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anabolic androgenic steroids--use and correlates among gym users--an assessment study using questionnaires and observations at gyms in the Stockholm region.
    Leifman H; Rehnman C; Sjöblom E; Holgersson S
    Int J Environ Res Public Health; 2011 Jul; 8(7):2656-74. PubMed ID: 21845151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Anabolic 500 survey: characteristics of male users versus nonusers of anabolic-androgenic steroids for strength training.
    Ip EJ; Barnett MJ; Tenerowicz MJ; Perry PJ
    Pharmacotherapy; 2011 Aug; 31(8):757-66. PubMed ID: 21923602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anabolic androgenic steroids used as performance and image enhancing drugs in professional and amateur athletes: Toxicological and psychopathological findings.
    Piacentino D; Sani G; Kotzalidis GD; Cappelletti S; Longo L; Rizzato S; Fabi F; Frati P; Fineschi V; Leggio L
    Hum Psychopharmacol; 2022 Jan; 37(1):e2815. PubMed ID: 34528289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical appearance concerns are uniquely associated with the severity of steroid dependence and depression in anabolic-androgenic steroid users.
    Griffiths S; Jacka B; Degenhardt L; Murray SB; Larance B
    Drug Alcohol Rev; 2018 Jul; 37(5):664-670. PubMed ID: 29484740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appearance and performance-enhancing drugs and supplements (APEDS): Lifetime use and associations with eating disorder and muscle dysmorphia symptoms among cisgender sexual minority people.
    Nagata JM; McGuire FH; Lavender JM; Brown TA; Murray SB; Compte EJ; Cattle CJ; Flentje A; Lubensky ME; Obedin-Maliver J; Lunn MR
    Eat Behav; 2022 Jan; 44():101595. PubMed ID: 35066385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Appearance- and Performance-Enhancing Drugs on Personality Traits.
    Zaami S; Minutillo A; Sirignano A; Marinelli E
    Front Psychiatry; 2021; 12():730167. PubMed ID: 34630182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heavy Testosterone Use Among Bodybuilders: An Uncommon Cohort of Illicit Substance Users.
    Westerman ME; Charchenko CM; Ziegelmann MJ; Bailey GC; Nippoldt TB; Trost L
    Mayo Clin Proc; 2016 Feb; 91(2):175-82. PubMed ID: 26769184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychiatric and medical effects of anabolic-androgenic steroid use in women.
    Gruber AJ; Pope HG
    Psychother Psychosom; 2000; 69(1):19-26. PubMed ID: 10601831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common symptoms associated with usage and cessation of anabolic androgenic steroids in men.
    Sharma A; Grant B; Islam H; Kapoor A; Pradeep A; Jayasena CN
    Best Pract Res Clin Endocrinol Metab; 2022 Sep; 36(5):101691. PubMed ID: 35999138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anabolic-androgenic steroid use disorders among a sample of Australian competitive and recreational users.
    Copeland J; Peters R; Dillon P
    Drug Alcohol Depend; 2000 Jul; 60(1):91-6. PubMed ID: 10821993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.